Superworth

Gain Therapeutics market cap GANX

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$49.3M
Highest close in our data
$149.4M
Dec 2025

Gain Therapeutics is worth $49.3M at the close on Nov 2, 2026, at $1.13 a share.

That is down 30% over the last year and down 47% over five years.

Its highest close in our data was $149.4M in Dec 2025.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$49.3M$49.3M$114.8M−57%
2025$113.7M$42.6M$149.4M+144%
2024$46.7M$19M$68.9M+11%
2023$42.2M$27.9M$65.4M+14%
2022$37.2M$31.7M$63.1M−42%
2021$64.5M$64.5M$126.4Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Gain Therapeutics' size, closest first, today.

CompanyMarket cap
GANXGain Therapeutics$49.3M
ATNMActinium Pharmaceuticals$45M
SPROSpero Therapeutics$60.6M
LFVNLifevantage$73.5M
NATRNatures Sunshine Products$211.5M
CRMDCorMedix$420.1M
ARVNArvinas$491.7M
Peer median$142.5M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Gain Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.